EURAX HYDROCORTISONE CREAM
Active substance(s): CROTAMITON / HYDROCORTISONE
Eurax® Hydrocortisone Cream
Crotamiton 10.0% w/w and Hydrocortisone 0.25% w/w
Read all of this leaflet carefully because it contains important information for you.
Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their
symptoms are the same as yours.
• If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell
your doctor or pharmacist.
In this leaflet:
1. What Eurax Hydrocortisone Cream is and what it is used for
2. Before you use Eurax Hydrocortisone Cream
3. How to use Eurax Hydrocortisone Cream
4. Possible side effects
5. How to store Eurax Hydrocortisone Cream
6. Further information
1. WHAT EURAX HYDROCORTISONE CREAM IS AND WHAT IT IS USED FOR
Eurax Hydrocortisone Cream is a skin cream to treat skin conditions such as eczema and dermatitis of all
types, including those listed below, and also insect bite reactions:
• Intense itching due to atopic eczema and primary irritant and allergic dermatitis,
• UV light sensitivity (photodermatitis),
• inflammation of the outer ear (otitis externa),
• inflammation between skin folds (intertrigo),
• itching from hard skin nodules (prurigo nodularis),
• inflammation caused by excessive secretion of the skin glands (seborrhoeic dermatitis).
2. BEFORE YOU USE EURAX HYDROCORTISONE CREAM
Do not use Eurax Hydrocortisone Cream if you:
• are allergic (hypersensitive) to any of the ingredients of Eurax Hydrocortisone Cream (see Section 6 and
Section 2 “Important information about some of the ingredients of Eurax Hydrocortisone Cream”),
• have a bacterial, viral or fungal infection of the skin
• have weeping open skin wounds (acute exudative dermatoses)
• have any ulcerated areas of skin
• are pregnant, or planning to become pregnant, or breast-feeding, without medical advice.
Do not put Eurax Hydrocortisone Cream in contact with the eyes (conjunctiva), mouth or mucous
membranes. In case of contact with eyes, rinse immediately with water.
Take special care with Eurax Hydrocortisone Cream:
• use with caution in infants; especially in the nappy area; do not use for not more than 7 days
• long-term continuous use should be avoided as this can lead to adrenal problems.
Taking other medicines
Please tell your doctor or pharmacist if you are taking, or have recently taken, any other medicines,
including those obtained without a prescription.
There are no known interactions between Eurax Hydrocortisone Cream and other medicines.
Pregnancy and breast-feeding
Ask your doctor or pharmacist for advice before taking any medicines. Eurax Hydrocortisone Cream is
not recommended for use in pregnancy as there is inadequate evidence of safety in pregnancy. Consult
your doctor if you are breast-feeding because it is not known if the active substances of Eurax
Hydrocortisone Cream pass into breast milk.
Driving and using machines
There is no evidence that Eurax Hydrocortisone Cream can affect your ability to drive or operate
Important information about some of the ingredients of Eurax Hydrocortisone Cream.
Eurax Hydrocortisone Cream contains stearyl alcohol, propylene glycol which may cause local allergic
skin reactions (contact dermatitis); propyl hydroxybenzoate (E216) and Methyl hydroxybenzoate (E218),
which may cause delayed allergic reactions. If this happens, stop using the cream.
Adults and the Elderly
Apply a thin layer of Eurax Hydrocortisone Cream to the affected area 2-3 times a day. Do not cover the
affected area with dressings. Do not use for more than 10-14 days (or for more than 7 days if applied to
Apply the cream once a day only in young children. A nappy should not be used if the cream is applied to
the nappy area. Do not use the cream for more than 7 days in infants.
Eurax Hydrocortisone Cream should not be used for more than 7 days without seeking medical advice.
If you use more Eurax Hydrocortisone Cream than you should
Eurax Hydrocortisone is for application to the skin only.
If you or a child accidentally ingests large amounts of Eurax Hydrocortisone Cream, contact your doctor
If you forget to use Eurax Hydrocortisone Cream
Do not apply more cream than you should to make up for a forgotten application.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
4. POSSIBLE SIDE EFFECTS
Like all medicines, Eurax Hydrocortisone Cream can cause side effects, although not everybody gets
Occasionally you may get skin irritation, such as a burning sensation, redness, itching, eczema, or contact
You should stop using the cream if you experience severe skin irritation.
If any of the side effects gets serious, or if you have any side effects not listed in this leaflet, please tell
your doctor or pharmacist.
5. HOW TO STORE EURAX HYDROCORTISONE CREAM
Keep out of the reach and sight of children. Do not store above 25°C. Protect from heat.
Do not use Eurax Hydrocortisone Cream after the ‘Use By’ date which is stated on the carton. The ‘Use
By’ date refers to the last day of that month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to
dispose of medicines no longer required. These measures will help to protect the environment.
6. FURTHER INFORMATION
What Eurax Hydrocortisone Cream contains
The active ingredients are: Crotamiton 10.0% w/w and Hydrocortisone 0.25% w/w
The other ingredients are: Stearyl alcohol, White soft paraffin, Polyoxy 40 stearate, Propyl
hydroxybenzoate (E216), Propylene glycol, Methyl hydroxybenzoate (E218), Perfume Givaudan no 45,
Purified water (see also Section 2 “Important information about some of the ingredients of Eurax
What Eurax Hydrocortisone Cream looks like and contents of the pack
Eurax Hydrocortisone Cream is a white cream and is available in 30g aluminium tubes.
Marketing Authorisation Holder and Manufacturer
GlaxoSmithKline Consumer Healthcare (UK) Trading Limited,
For any information about this medicinal product, please contact the Marketing Authorisation Holder.
This leaflet was last revised in May 2016.